Figure 1: Western Blot - Anti-GSK3 beta (phospho Ser9) Antibody (A94909)
Western blot analysis of lysates from HeLa cells treated with EGF using Anti-GSK3 beta (phospho Ser9) Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Anti-GSK3 beta (phospho Ser9) Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.
Immunohistochemical analysis of paraffin-embedded human uterus tissue using Anti-GSK3 beta (phospho Ser9) Antibody at 1:200 (4°C overnight). Negative control was secondary antibody only.
Immunohistochemical analysis of paraffin-embedded human uterus cancer tissue using Anti-GSK3 beta (phospho Ser9) Antibody at 1:200 (4°C overnight). Negative control was secondary antibody only.
Immunofluorescence analysis of rat spleen tissue using Anti-GSK3 beta (phospho Ser9) Antibody (red) at 1:200 (4°C overnight). Cy3 labelled secondary antibody was used at 1:300 (RT 50min). Panel A: Target. Panel B: DAPI. Panel C: Merge.
Immunofluorescence analysis of rat spleen tissue using Anti-GSK3 beta (phospho Ser9) Antibody (red) at 1:200 (4°C overnight). Cy3 labelled secondary antibody was used at 1:300 (RT 50min). Panel A: Target. Panel B: DAPI. Panel C: Merge.
